As scientists worldwide scramble for COVID-19 treatments and cures, some see promise in antibody-rich plasma of survivors. In Canada and beyond survivors are donating their blood for new, fast-tracked, clinical trials. Today, CBC senior correspondent Susan Ormiston joins us from Washington, D.C., to explain why antibody-rich plasma could be useful in the fight against COVID-19.
